Universidad de Cantabria - IDIVAL, Santander, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
BMC Cancer. 2018 Mar 12;18(1):280. doi: 10.1186/s12885-018-4182-3.
Reproductive factors are well known risk factors for breast cancer; however, little is known about how genetic variants in hormonal pathways interact with that relationship.
One thousand one hundred thirty nine cases of breast cancer in women and 1322 frequency-matched controls were compared. Genetic variants in hormonal pathways (identified in the Kyoto Encyclopedia of Genes and Genomes) were screened according to their relationship with breast cancer using the Cochran-Armitage statistic. Information on reproductive factors was obtained using a face-to-face questionnaire. The interaction among the selected genetic variants and reproductive factors was tested with logistic regression.
Concerning C allele in rs2229712, compared to nulliparity in non-carriers the ORs for 1-2 and > 2 deliveries were 0.48 (0.28-0.81) and 0.34 (0.19-0.59), and in C carriers they were 0.92 (0.42-1.98) and 0.71 (0.31-1.61). Similar results were found in women carrying the C allele in rs1269851. Carriers of Allele T in rs35652107 and allele C in rs6018027 had the delivery number effect more pronounced.
The number of deliveries had a dose-response protective effect on breast cancer; women carrying C allele in rs2229712 did not benefit from this protective effect.
生殖因素是众所周知的乳腺癌危险因素;然而,关于激素途径中的遗传变异如何与这种关系相互作用,知之甚少。
将 1139 例女性乳腺癌病例和 1322 例频率匹配的对照进行比较。根据与乳腺癌的关系,使用 Cochran-Armitage 统计量筛选激素途径中的遗传变异(在京都基因与基因组百科全书中确定)。使用面对面问卷获取生殖因素信息。使用逻辑回归检验所选遗传变异与生殖因素之间的相互作用。
关于 rs2229712 中的 C 等位基因,与非携带者的未婚相比,1-2 次和>2 次分娩的 OR 值分别为 0.48(0.28-0.81)和 0.34(0.19-0.59),而在 C 携带者中分别为 0.92(0.42-1.98)和 0.71(0.31-1.61)。在携带 rs1269851 中 C 等位基因的女性中也发现了类似的结果。携带 rs35652107 中的 T 等位基因和 rs6018027 中的 C 等位基因的女性,其分娩次数的影响更为明显。
分娩次数对乳腺癌具有剂量反应保护作用;携带 rs2229712 中 C 等位基因的女性不能从中受益。